3-Chlorothiophene-2-carbonyl chloride → 2-[5-(3-Chloro-2-thienyl)-1,2,4-oxadiazol-3-yl]pyrazine
반응식
[N:1]1[CH:6]=[CH:5][N:4]=[CH:3][C:2]=1[C:7](=[N:9][OH:10])[NH2:8].[Cl:11][C:12]1[CH:16]=[CH:15][S:14][C:13]=1[C:17](Cl)=O>>[Cl:11][C:12]1[CH:16]=[CH:15][S:14][C:13]=1[C:17]1[O:10][N:9]=[C:7]([C:2]2[CH:3]=[N:4][CH:5]=[CH:6][N:1]=2)[N:8]=1참가 물질
3
실험 절차
The title compound was prepared from pyrazine-2-amidoxime (42.2 mg, 0.306 mmol) and 3-chloro-thiophene-2-carbonyl chloride (55 mg, 0.30 mmol) similar to Example 16, and yielded 67.4 mg (84%) of white solid. 1H NMR (CDCl3): 9.45 (d, J=1.37 Hz, 1H), 8.81 (dd, J=2.48, 1.65 Hz, 1H), 8.77 (d, J=2.47 Hz, 1H), 7.66 (d, J=4.95 Hz, 1H), 7.16 (d, J=5.50 Hz, 1H).
출처 및 근거
- ORD 기록
- ord-ffab7f8d880548c884451bf896ea1280
- 출처 데이터셋
- uspto-grants-2008_10
- 특허 번호
- US07435750B2
반응 노트
불러오는 중…